CSIR-CCMB Hyderabad developed DNA barcoding technology

Hyderabad:  Identifying the quality of medicinal plants used in Ayurvedic medicines has always remained a challenge, especially in preventing adulteration. While it is possible to identify plants to some extent by their appearance, the task becomes extremely difficult when the raw material is in powdered form or consists only of roots.

To address this issue, scientists at the Centre for Cellular and Molecular Biology (CSIR-CCMB) in Hyderabad have developed a solution using DNA barcoding technology through which medicinal plants can be identified with high accuracy. DNA barcoding is a scientific method that identifies species using a small segment of DNA present in living organisms.

Although this technique is used widely, plant identification through DNA barcoding is more complex compared to animals. To overcome the challenge, CCMB scientists have developed a special DNA barcode system specifically designed for plants. As part of the initiative, CCMB is currently training Ayurvedic practitioners and experts in using this advanced technology. The initiative was conducted under the aegis of the Union Ministry of AYUSH and the Rashtriya Ayurveda Vidyapeeth.

The process begins with isolating DNA from the medicinal plant sample, which is then amplified using Polymerase Chain Reaction (PCR) technology. Following this, DNA sequencing is carried out to analyse the plant genome. Based on this analysis, a unique DNA barcode is generated for each plant species, providing a precise digital identity.

The barcode data is stored in a database, where special software analyses the information. This enables scientists and experts to accurately determine whether a medicinal plant is genuine or adulterated. CCMB scientists believe this technology will play a crucial role in ensuring the purity, quality, and safety of medicinal plants used in Ayurvedic formulations, thereby strengthening trust in traditional medicine systems.

Related Posts

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’